YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma

PURPOSE: Although YAP1 and TAZ are believed to be equivalent downstream effectors of the Hippo pathway, differential expression of YAP1 or TAZ suggests distinct functions during cancer progression. The exact role of YAP1 and TAZ in esophageal cancer, the 6th leading cancer-related mortality in the w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Yi-Zih, Kang, Ya-Rong, Chang, Wei-Lun, Sim, Lydia Chin-Ling, Hsieh, Tzu-Chin, Chang, Chu-Han, Wang, Yi-Ching, Tsai, Ching-Jung, Huang, Li-Chun, Tsai, Sen-Tien, Wu, Li-Wha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579103/
https://www.ncbi.nlm.nih.gov/pubmed/35930163
http://dx.doi.org/10.1007/s13402-022-00695-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579103/
https://www.ncbi.nlm.nih.gov/pubmed/35930163
http://dx.doi.org/10.1007/s13402-022-00695-4

Ejemplares similares